OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RNA methylations in human cancers
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Roles of RNA Methylation on Tumor Immunity and Clinical Implications
Maorun Zhang, Junmin Song, Weitang Yuan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125

Small RNA modifications: regulatory molecules and potential applications
Qunli Xiong, Yaguang Zhang
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 48

The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 25

Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer
Zhidong Huang, Junfan Pan, Helin Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 88

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
Jinhui Liu, Can Chen, Yichun Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62

Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer
Miaomiao Huo, Jingyao Zhang, Wei Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 58

LINC02159 promotes non-small cell lung cancer progression via ALYREF/YAP1 signaling
Yang Qiu-rong, Maoye Wang, Jing Xu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 35

Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA
Shuai-Jun Chen, Jun Zhang, Ting Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102975-102975
Open Access | Times Cited: 33

Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
Ting Liu, Kun Yang, Jiamin Chen, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 326-326
Open Access | Times Cited: 32

Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification
Kanghui Liu, Peng Xu, Jialun Lv, et al.
Oncogene (2023) Vol. 42, Iss. 24, pp. 1980-1993
Closed Access | Times Cited: 32

tRNA modifications: insights into their role in human cancers
Ye Wang, En‐Wei Tao, Juan Tan, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 29

NSUN2‐mediated m5C RNA methylation dictates retinoblastoma progression through promoting PFAS mRNA stability and expression
Sipeng Zuo, Lin Li, Xuyang Wen, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 25

The functions and mechanisms of post-translational modification in protein regulators of RNA methylation: Current status and future perspectives
Youming Chen, Zuli Jiang, Ying Yang, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126773-126773
Closed Access | Times Cited: 22

Research progress of N1-methyladenosine RNA modification in cancer
Yafeng Liu, Shujun Zhang, Xiaohui Gao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13

NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization
Zhen Zhao, Yujie Zhou, Peng Lv, et al.
Cancer Letters (2024) Vol. 597, pp. 217059-217059
Open Access | Times Cited: 8

M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets
Mengzhen Han, Qibo Huang, Xinxin Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 4, pp. 1238-1255
Open Access | Times Cited: 7

Detection, molecular function and mechanisms of m5C in cancer
Linhui Zhang, Yuelong Li, Liqing Li, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1

RNA modifications in cardiovascular diseases, the potential therapeutic targets
Yirong Wu, Siyao Zhan, Yizhou Xu, et al.
Life Sciences (2021) Vol. 278, pp. 119565-119565
Closed Access | Times Cited: 52

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
Shijie Chen, Jin Zeng, Liping Huang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 32

Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke
Fangfang Zhang, Yuanyuan Ran, Muhammad Mobeen Tahir, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 32

Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches
Ping Yue, Bing-Jie Han, Yi Zhao
Molecular Omics (2023) Vol. 19, Iss. 4, pp. 297-307
Closed Access | Times Cited: 18

RNA m6A methylation regulators in liver cancer
Qiaoping Xu, Ning Ren, Lanqi Ren, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top